Oral Contraceptives and the Risk of Ductal Breast Carcinoma in situ

Author： Claus E.B.  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.81, Iss.2, 2003-09, pp. : 129-136

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiogenesis and invasive recurrence in ductal carcinoma in situ of the breast

By Teo N.B.   Shoker B.S.   Jarvis C.   Martin L.   Sloane J.P.   Holcombe C.  

European Journal of Cancer, Vol. 39, Iss. 1, 2003-01 ,pp. : 38-44

Elsevier

Access to resources Recommend Favorite

Gene amplification in ductal carcinoma in situ of the breast

By Burkhardt L.  

Breast Cancer Research and Treatment, Vol. 123, Iss. 3, 2010-10 ,pp. : 757-765

Springer Publishing Company

Access to resources Recommend Favorite

The natural history of ductal carcinoma in situ of the breast: a review

By Erbas Bircan   Provenzano Elena   Armes Jane   Gertig Dorota  

Breast Cancer Research and Treatment, Vol. 97, Iss. 2, 2006-05 ,pp. : 135-144

Springer Publishing Company

Access to resources Recommend Favorite

Histopathology of Ductal Carcinoma in Situ (DCIS) of the Breast

By  

Current Cancer Therapy Reviews, Vol. 8, Iss. 3, 2012-08 ,pp. : 162-171

Bentham Science Publishers

Access to resources Recommend Favorite

Oral contraceptive use and risk of breast carcinoma in situ (United States)

By Gill Jasmeet   Press Michael   Patel Alpa   Bernstein Leslie  

Cancer Causes and Control, Vol. 17, Iss. 9, 2006-11 ,pp. : 1155-1162

Springer Publishing Company

Access to resources Recommend Favorite